Home/Filings/4/0001894562-23-000004
4//SEC Filing

Brudnick Richard 4

Accession 0001894562-23-000004

CIK 0001894562other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 8:22 PM ET

Size

5.4 KB

Accession

0001894562-23-000004

Insider Transaction Report

Form 4
Period: 2023-03-31
Brudnick Richard
Chief Business Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-31+135,747135,747 total
    Exercise: $12.30Exp: 2033-03-31Common Stock (135,747 underlying)
Footnotes (1)
  • [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 31, 2023, subject to the Reporting Person's continued service on each such vesting date.

Issuer

Prime Medicine, Inc.

CIK 0001894562

Entity typeother

Related Parties

1
  • filerCIK 0001692359

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 8:22 PM ET
Size
5.4 KB